{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:27:28Z","timestamp":1791070048417,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T00:00:00Z","timestamp":1214352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00431-008-0745-7","type":"journal-article","created":{"date-parts":[[2008,6,24]],"date-time":"2008-06-24T14:55:49Z","timestamp":1214319349000},"page":"965-971","source":"Crossref","is-referenced-by-count":20,"title":["What\u2019s new in haemolytic uraemic syndrome?"],"prefix":"10.1007","volume":"167","author":[{"given":"Sally","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Mark","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,25]]},"reference":[{"key":"745_CR1","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1542\/peds.2004-2236","volume":"115","author":"JA Ake","year":"2005","unstructured":"Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI (2005) Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115:e673\u2013e680","journal-title":"Pediatrics"},{"key":"745_CR2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","volume":"70","author":"N Besbas","year":"2006","unstructured":"Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB (2006) A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70:423\u2013431","journal-title":"Kidney Int"},{"key":"745_CR3","doi-asserted-by":"crossref","first-page":"e1024","DOI":"10.1371\/journal.pone.0001024","volume":"2","author":"M Bielaszewska","year":"2007","unstructured":"Bielaszewska M (2007) Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm. PLoS ONE 2:e1024","journal-title":"PLoS ONE"},{"key":"745_CR4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2215\/CJN.00050505","volume":"1","author":"E Bresin","year":"2006","unstructured":"Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Hill P, Goodship TH, Remuzzi G (2006) Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Clin J Am Soc Nephrol 1:88\u201399","journal-title":"Clin J Am Soc Nephrol"},{"key":"745_CR5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","volume":"12","author":"J Caprioli","year":"2001","unstructured":"Caprioli J, Bettinaglio P, Zipfel PF, Amadei B, Daina E, Gamba S, Skerka C, Marziliano N, Remuzzi G, Noris M (2001) The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 12:297\u2013307","journal-title":"J Am Soc Nephrol"},{"key":"745_CR6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","volume":"108","author":"J Caprioli","year":"2006","unstructured":"Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, Mele C, Bresin E, Cassis L, Gamba S, Porrati F, Bucchioni S, Monteferrante G, Fang CJ, Liszewski MK, Kavanagh D, Atkinson JP, Remuzzi G (2006) Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108:1267\u20131279","journal-title":"Blood"},{"key":"745_CR7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mib.2005.12.008","volume":"9","author":"E Caron","year":"2006","unstructured":"Caron E, Crepin VF, Simpson N, Knutton S, Garmendia J, Frankel G (2006) Subversion of actin dynamics by EPEC and EHEC. Curr Opin Microbiol 9:40\u201345","journal-title":"Curr Opin Microbiol"},{"key":"745_CR8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00467-003-1371-2","volume":"19","author":"HI Cheong","year":"2004","unstructured":"Cheong HI, Lee BS, Kang HG, Hahn H, Suh KS, Ha IS, Choi Y (2004) Attempted treatment of factor H deficiency by liver transplantation. Pediatr Nephrol 19:454\u2013458","journal-title":"Pediatr Nephrol"},{"key":"745_CR9","doi-asserted-by":"crossref","first-page":"c118","DOI":"10.1159\/000078640","volume":"97","author":"S Dieguez","year":"2004","unstructured":"Dieguez S, Ayuso S, Brindo M, Osinde E, Canepa C (2004) Renal functional reserve evolution in children with a previous episode of hemolytic uremic syndrome. Nephron Clin Pract 97:c118\u2013c122","journal-title":"Nephron Clin Pract"},{"key":"745_CR10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","volume":"16","author":"MA Dragon-Durey","year":"2005","unstructured":"Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Fremeaux-Bacchi V (2005) Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 16:555\u2013563","journal-title":"J Am Soc Nephrol"},{"key":"745_CR11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/adc.85.2.125","volume":"85","author":"EJ Elliott","year":"2001","unstructured":"Elliott EJ, Robins-Browne RM, O\u2019Loughlin EV, Bennett-Wood V, Bourke J, Henning P, Hogg GG, Knight J, Powell H, Redmond D (2001) Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 85:125\u2013131","journal-title":"Arch Dis Child"},{"key":"745_CR12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","volume":"14","author":"J Esparza-Gordillo","year":"2005","unstructured":"Esparza-Gordillo J, Goicoechea de Jorge E, Buil A, Carreras Berges L, Lopez-Trascasa M, Sanchez-Corral P, Rodriguez de Cordoba S (2005) Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 14:703\u2013712","journal-title":"Hum Mol Genet"},{"key":"745_CR13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-2958.1998.01144.x","volume":"30","author":"G Frankel","year":"1998","unstructured":"Frankel G, Phillips AD, Rosenshine I, Dougan G, Kaper JB, Knutton S (1998) Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol Microbiol 30:911\u2013921","journal-title":"Mol Microbiol"},{"key":"745_CR14","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1600-6143.2007.01888.x","volume":"7","author":"V Fremeaux-Bacchi","year":"2007","unstructured":"Fremeaux-Bacchi V, Arzouk N, Ferlicot S, Charpentier B, Snanoudj R, Durrbach A (2007) Recurrence of HUS due to CD46\/MCP mutation after renal transplantation: a role for endothelial microchimerism. Am J Transplant 7:2047\u20132051","journal-title":"Am J Transplant"},{"key":"745_CR15","volume-title":"Mutations in complement C3 predispose to development of atypical haemolytic uraemic syndrome. In: XIth European meeting on complement in human disease","author":"VGT Fremeaux-Bacchi","year":"2007","unstructured":"Fremeaux-Bacchi VGT, Regnier CH, Dragon-Durey MA, Janssen B, Atkinson J (2007) Mutations in complement C3 predispose to development of atypical haemolytic uraemic syndrome. In: XIth European meeting on complement in human disease. Elsevier, Cardiff, UK"},{"key":"745_CR16","doi-asserted-by":"crossref","unstructured":"Fremeaux-Bacchi V, Kemp EJ, Goodship JA, Dragon-Durey M-A, Strain L, Loirat C, Deng H-W, Goodship THJ (2005) The development of atypical HUS is influenced by susceptibility factors in factor H and membrane cofactor protein\u2014evidence from two independent cohorts. J Med Genet 42(11):852\u2013856","DOI":"10.1136\/jmg.2005.030783"},{"key":"745_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/338115","volume":"185","author":"AW Friedrich","year":"2002","unstructured":"Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, Ammon A, Karch H (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185:74\u201384","journal-title":"J Infect Dis"},{"key":"745_CR18","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","volume":"290","author":"AX Garg","year":"2003","unstructured":"Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF (2003) Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290:1360\u20131370","journal-title":"JAMA"},{"key":"745_CR19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/341940","volume":"186","author":"A Gerber","year":"2002","unstructured":"Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB (2002) Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997\u20132000, in Germany and Austria: a prospective study. J Infect Dis 186:493\u2013500","journal-title":"J Infect Dis"},{"key":"745_CR20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.2006091069","volume":"18","author":"S Heinen","year":"2007","unstructured":"Heinen S, Jozsi M, Hartmann A, Noris M, Remuzzi G, Skerka C, Zipfel PF (2007) Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells. J Am Soc Nephrol 18:506\u2013514","journal-title":"J Am Soc Nephrol"},{"key":"745_CR21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-6143.2007.02029.x","volume":"8","author":"H Jalanko","year":"2008","unstructured":"Jalanko H, Peltonen S, Koskinen A, Puntila J, Isoniemi H, Holmberg C, Pinomaki A, Armstrong E, Koivusalo A, Tukiainen E, Makisalo H, Saland J, Remuzzi G, de Cordoba S, Lassila R, Meri S, Jokiranta TS (2008) Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J Transplant 8:216\u2013221","journal-title":"Am J Transplant"},{"key":"745_CR22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9440(10)61205-9","volume":"167","author":"TS Jokiranta","year":"2005","unstructured":"Jokiranta TS, Cheng ZZ, Seeberger H, Jozsi M, Heinen S, Noris M, Remuzzi G, Ormsby R, Gordon DL, Meri S, Hellwage J, Zipfel PF (2005) Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. Am J Pathol 167:1173\u20131181","journal-title":"Am J Pathol"},{"key":"745_CR23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.2005080868","volume":"17","author":"M Jozsi","year":"2006","unstructured":"Jozsi M, Heinen S, Hartmann A, Ostrowicz CW, Halbich S, Richter H, Kunert A, Licht C, Saunders RE, Perkins SJ, Zipfel PF, Skerka C (2006) Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions. J Am Soc Nephrol 17:170\u2013177","journal-title":"J Am Soc Nephrol"},{"key":"745_CR24","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","volume":"111","author":"M Jozsi","year":"2008","unstructured":"Jozsi M, Licht C, Strobel S, Zipfel SLH, Richter H, Heinen S, Zipfel PF, Skerka C (2008) Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency. Blood 111:1512\u20131514","journal-title":"Blood"},{"key":"745_CR25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1574-6968.1986.tb01516.x","volume":"35","author":"H Karch","year":"1986","unstructured":"Karch H, Strockbine NA, O\u2019Brien AD (1986) Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay. FEMS Microbiol Lett 35:141\u2013145","journal-title":"FEMS Microbiol Lett"},{"key":"745_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/CMR.2.1.15","volume":"2","author":"MA Karmali","year":"1989","unstructured":"Karmali MA (1989) Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 2:15\u201338","journal-title":"Clin Microbiol Rev"},{"key":"745_CR27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2215\/CJN.03270906","volume":"2","author":"D Kavanagh","year":"2007","unstructured":"Kavanagh D, Richards A, Fremeaux-Bacchi V, Noris M, Goodship T, Remuzzi G, Atkinson JP (2007) Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2:591\u2013596","journal-title":"Clin J Am Soc Nephrol"},{"key":"745_CR28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molimm.2007.05.004","volume":"45","author":"D Kavanagh","year":"2008","unstructured":"Kavanagh D, Richards A, Noris M, Hauhart R, Liszewski MK, Karpman D, Goodship JA, Fremeaux-Bacchi V, Remuzzi G, Goodship TH, Atkinson JP (2008) Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome. Mol Immunol 45:95\u2013105","journal-title":"Mol Immunol"},{"key":"745_CR29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/adc.65.7.722","volume":"65","author":"H Kleanthous","year":"1990","unstructured":"Kleanthous H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, Milford DV (1990) Haemolytic uraemic syndromes in the British Isles, 1985\u20138: association with verocytotoxin producing Escherichia coli. Part 2: microbiological aspects. Arch Dis Child 65:722\u2013727","journal-title":"Arch Dis Child"},{"key":"745_CR30","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1128\/JCM.39.6.2272-2279.2001","volume":"39","author":"K Ludwig","year":"2001","unstructured":"Ludwig K, Karmali MA, Sarkim V, Bobrowski C, Petric M, Karch H, Muller-Wiefel DE (2001) Antibody response to shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol 39:2272\u20132279","journal-title":"J Clin Microbiol"},{"key":"745_CR31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3201\/eid1104.040833","volume":"11","author":"RM Lynn","year":"2005","unstructured":"Lynn RM, O\u2019Brien SJ, Taylor CM, Adak GK, Chart H, Cheasty T, Coia JE, Gillespie IA, Locking ME, Reilly WJ, Smith HR, Waters A, Willshaw GA (2005) Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis 11:590\u2013596","journal-title":"Emerg Infect Dis"},{"key":"745_CR32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3476(98)70223-9","volume":"133","author":"NE Moghal","year":"1998","unstructured":"Moghal NE, Ferreira MA, Howie AJ, Milford DV, Raafat E, Taylor CM (1998) The late histologic findings in diarrhea-associated hemolytic uremic syndrome. J Pediatr 133:220\u2013223","journal-title":"J Pediatr"},{"key":"745_CR33","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/IAI.70.2.612-619.2002","volume":"70","author":"J Mukherjee","year":"2002","unstructured":"Mukherjee J, Chios K, Fishwild D, Hudson D, O\u2019Donnell S, Rich SM, Donohue-Rolfe A, Tzipori S (2002) Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection. Infect Immun 70:612\u2013619","journal-title":"Infect Immun"},{"key":"745_CR34","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/ki.1997.487","volume":"52","author":"M Nangaku","year":"1997","unstructured":"Nangaku M, Alpers CE, Pippin J, Shankland SJ, Kurokawa K, Adler S, Johnson RJ, Couser WG (1997) Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9. Kidney Int 52:1570\u20131578","journal-title":"Kidney Int"},{"key":"745_CR35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/jmg.40.9.676","volume":"40","author":"HP Neumann","year":"2003","unstructured":"Neumann HP, Salzmann M, Bohnert-Iwan B, Mannuelian T, Skerka C, Lenk D, Bender BU, Cybulla M, Riegler P, Konigsrainer A, Neyer U, Bock A, Widmer U, Male DA, Franke G, Zipfel PF (2003) Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet 40:676\u2013681","journal-title":"J Med Genet"},{"key":"745_CR36","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","volume":"362","author":"M Noris","year":"2003","unstructured":"Noris M, Brioschi S, Caprioli J, Todeschini M, Bresin E, Porrati F, Gamba S, Remuzzi G (2003) Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362:1542\u20131547","journal-title":"Lancet"},{"key":"745_CR37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s004670050515","volume":"12","author":"M Ohali","year":"1998","unstructured":"Ohali M, Shalev H, Schlesinger M, Katz Y, Kachko L, Carmi R, Sofer S, Landau D (1998) Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H. Pediatr Nephrol 12:619\u2013624","journal-title":"Pediatr Nephrol"},{"key":"745_CR38","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/508207","volume":"43","author":"D Orth","year":"2006","unstructured":"Orth D, Wurzner R (2006) What makes an enterohemorrhagic Escherichia coli? Clin Infect Dis 43:1168\u20131169","journal-title":"Clin Infect Dis"},{"key":"745_CR39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","volume":"68","author":"D Perez-Caballero","year":"2001","unstructured":"Perez-Caballero D, Gonzalez-Rubio C, Gallardo ME, Vera M, Lopez-Trascasa M, Rodriguez de Cordoba S, Sanchez-Corral P (2001) Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet 68:478\u2013484","journal-title":"Am J Hum Genet"},{"key":"745_CR40","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/JCM.38.3.1023-1031.2000","volume":"38","author":"N Pradel","year":"2000","unstructured":"Pradel N, Livrelli V, De Champs C, Palcoux J-B, Reynaud A, Scheutz F, Sirot J, Joly B, Forestier C (2000) Prevalence and characterization of shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. J Clin Microbiol 38:1023\u20131031","journal-title":"J Clin Microbiol"},{"key":"745_CR41","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(02)08560-4","volume":"359","author":"G Remuzzi","year":"2002","unstructured":"Remuzzi G, Ruggenenti P, Codazzi D, Noris M, Caprioli J, Locatelli G, Gridelli B (2002) Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 359:1671\u20131672","journal-title":"Lancet"},{"key":"745_CR42","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2005.00783.x","volume":"5","author":"G Remuzzi","year":"2005","unstructured":"Remuzzi G, Ruggenenti P, Colledan M, Gridelli B, Bertani A, Bettinaglio P, Bucchioni S, Sonzogni A, Bonanomi E, Sonzogni V, Platt JL, Perico N, Noris M (2005) Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation. Am J Transplant 5:1146\u20131150","journal-title":"Am J Transplant"},{"key":"745_CR43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/318203","volume":"68","author":"A Richards","year":"2001","unstructured":"Richards A, Buddles MR, Donne RL, Kaplan BS, Kirk E, Venning MC, Tielemans CL, Goodship JA, Goodship TH (2001) Factor H mutations in hemolytic uremic syndrome cluster in exons 18\u201320, a domain important for host cell recognition. Am J Hum Genet 68:485\u2013490","journal-title":"Am J Hum Genet"},{"key":"745_CR44","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","volume":"100","author":"A Richards","year":"2003","unstructured":"Richards A, Kemp EJ, Liszewski MK, Goodship JA, Lampe AK, Decorte R, Muslumanogglu MH, Kavukcu S, Filler G, Pirson Y, Wen LS, Atkinson JP, Goodship THJ (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. PNAS 100:12966\u201312971","journal-title":"PNAS"},{"key":"745_CR45","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.288.8.996","volume":"288","author":"N Safdar","year":"2002","unstructured":"Safdar N, Said A, Gangnon RE, Maki DG (2002) Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA 288:996\u20131001","journal-title":"JAMA"},{"key":"745_CR46","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1600-6143.2006.01375.x","volume":"6","author":"JM Saland","year":"2006","unstructured":"Saland JM, Emre SH, Shneider BL, Benchimol C, Ames S, Bromberg JS, Remuzzi G, Strain L, Goodship TH (2006) Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant 6:1948\u20131952","journal-title":"Am J Transplant"},{"key":"745_CR47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molimm.2004.01.003","volume":"41","author":"P Sanchez-Corral","year":"2004","unstructured":"Sanchez-Corral P, Gonzalez-Rubio C, Rodriguez de Cordoba S, Lopez-Trascasa M (2004) Functional analysis in serum from atypical hemolytic uremic syndrome patients reveals impaired protection of host cells associated with mutations in factor H. Mol Immunol 41:81\u201384","journal-title":"Mol Immunol"},{"key":"745_CR48","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/344515","volume":"71","author":"P Sanchez-Corral","year":"2002","unstructured":"Sanchez-Corral P, Perez-Caballero D, Huarte O, Simckes AM, Goicoechea E, Lopez-Trascasa M, de Cordoba SR (2002) Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am J Hum Genet 71:1285\u20131295","journal-title":"Am J Hum Genet"},{"key":"745_CR49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/humu.20268","volume":"27","author":"RE Saunders","year":"2006","unstructured":"Saunders RE, Goodship TH, Zipfel PF, Perkins SJ (2006) An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations. Hum Mutat 27:21\u201330","journal-title":"Hum Mutat"},{"key":"745_CR50","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C (2007) Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 18:2392\u20132400","journal-title":"J Am Soc Nephrol"},{"key":"745_CR51","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1128\/IAI.71.6.3125-3130.2003","volume":"71","author":"AS Sheoran","year":"2003","unstructured":"Sheoran AS, Chapman S, Singh P, Donohue-Rolfe A, Tzipori S (2003) Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants. Infect Immun 71:3125\u20133130","journal-title":"Infect Immun"},{"key":"745_CR52","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/jama.290.10.1337","volume":"290","author":"H Trachtman","year":"2003","unstructured":"Trachtman H, Cnaan A, Christen E, Gibbs K, Zhao S, Acheson DWK, Weiss R, Kaskel FJ, Spitzer A, Hirschman GH (2003) Effect of an oral shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. JAMA 290:1337\u20131344","journal-title":"JAMA"},{"key":"745_CR53","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1067\/mpd.2003.79","volume":"142","author":"A Veyradier","year":"2003","unstructured":"Veyradier A, Obert B, Haddad E, Cloarec S, Nivet H, Foulard M, Lesure F, Delattre P, Lakhdari M, Meyer D, Girma J-P, Loriat C (2003) Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome. J Pediatr 142:310\u2013317","journal-title":"J Pediatr"},{"key":"745_CR54","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","volume":"53","author":"P Warwicker","year":"1998","unstructured":"Warwicker P, Goodship TH, Donne RL, Pirson Y, Nicholls A, Ward RM, Turnpenny P, Goodship JA (1998) Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 53:836\u2013844","journal-title":"Kidney Int"},{"key":"745_CR55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2007.03.055","volume":"151","author":"AM Waters","year":"2007","unstructured":"Waters AM, Kerecuk L, Luk D, Haq MR, Fitzpatrick MM, Gilbert RD, Inward C, Jones C, Pichon B, Reid C, Slack MPE, Van\u2019t Hoff W, Dillon MJ, Taylor CM, Tullus K (2007) Hemolytic uremic syndrome associated with invasive pneumococcal disease: The United Kingdom experience. J Pediatr 151:140\u2013144","journal-title":"J Pediatr"},{"key":"745_CR56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/aje\/kwk023","volume":"165","author":"D Werber","year":"2007","unstructured":"Werber D, Behnke SC, Fruth A, Merle R, Menzler S, Glaser S, Kreienbrock L, Prager R, Tschape H, Roggentin P, Bockemuhl J, Ammon A (2007) Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups. Am J Epidemiol 165:425\u2013434","journal-title":"Am J Epidemiol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-008-0745-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-008-0745-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-008-0745-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:33:40Z","timestamp":1684452820000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-008-0745-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,25]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1007\/s00431-008-0745-7","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,25]]}}}